Free Trial

OmniAb (OABI) Competitors

OmniAb logo
$3.38 -0.04 (-1.02%)
As of 02:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OABI vs. RAMP, APLD, ASTH, GDRX, STGW, QBTS, PINC, SEZL, PHR, and DGNX

Should you be buying OmniAb stock or one of its competitors? The main competitors of OmniAb include LiveRamp (RAMP), Applied Digital (APLD), Astrana Health (ASTH), GoodRx (GDRX), Stagwell (STGW), D-Wave Quantum (QBTS), Premier (PINC), Sezzle (SEZL), Phreesia (PHR), and Diginex (DGNX). These companies are all part of the "business services" industry.

OmniAb vs.

LiveRamp (NYSE:RAMP) and OmniAb (NASDAQ:OABI) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, community ranking, valuation, risk and institutional ownership.

LiveRamp has a net margin of 0.01% compared to OmniAb's net margin of -308.78%. LiveRamp's return on equity of 0.97% beat OmniAb's return on equity.

Company Net Margins Return on Equity Return on Assets
LiveRamp0.01% 0.97% 0.75%
OmniAb -308.78%-20.97%-18.05%

LiveRamp received 147 more outperform votes than OmniAb when rated by MarketBeat users. However, 100.00% of users gave OmniAb an outperform vote while only 70.25% of users gave LiveRamp an outperform vote.

CompanyUnderperformOutperform
LiveRampOutperform Votes
170
70.25%
Underperform Votes
72
29.75%
OmniAbOutperform Votes
23
100.00%
Underperform Votes
No Votes

93.8% of LiveRamp shares are held by institutional investors. Comparatively, 72.1% of OmniAb shares are held by institutional investors. 3.4% of LiveRamp shares are held by company insiders. Comparatively, 8.6% of OmniAb shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

LiveRamp has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, OmniAb has a beta of -0.12, suggesting that its share price is 112% less volatile than the S&P 500.

In the previous week, LiveRamp had 6 more articles in the media than OmniAb. MarketBeat recorded 7 mentions for LiveRamp and 1 mentions for OmniAb. OmniAb's average media sentiment score of 1.89 beat LiveRamp's score of 0.48 indicating that OmniAb is being referred to more favorably in the news media.

Company Overall Sentiment
LiveRamp Neutral
OmniAb Very Positive

LiveRamp currently has a consensus price target of $39.83, suggesting a potential upside of 36.60%. OmniAb has a consensus price target of $9.00, suggesting a potential upside of 167.46%. Given OmniAb's stronger consensus rating and higher probable upside, analysts plainly believe OmniAb is more favorable than LiveRamp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LiveRamp
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
OmniAb
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

LiveRamp has higher revenue and earnings than OmniAb. OmniAb is trading at a lower price-to-earnings ratio than LiveRamp, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LiveRamp$728.71M2.63$11.88M$0.012,916.10
OmniAb$20.41M23.28-$50.62M-$0.62-5.43

Summary

LiveRamp beats OmniAb on 11 of the 17 factors compared between the two stocks.

Get OmniAb News Delivered to You Automatically

Sign up to receive the latest news and ratings for OABI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OABI vs. The Competition

MetricOmniAbCommercial physical research IndustryMedical SectorNASDAQ Exchange
Market Cap$475.19M$3.65B$5.81B$8.32B
Dividend YieldN/A2.03%4.76%3.97%
P/E Ratio-5.43109.9024.8719.01
Price / Sales23.28223.13374.09109.96
Price / CashN/A34.5738.0534.62
Price / Book1.252.737.234.20
Net Income-$50.62M$113.28M$3.19B$246.79M
7 Day Performance-6.27%-10.65%-3.99%-4.74%
1 Month Performance1.66%-6.67%-7.81%-7.84%
1 Year Performance-40.34%-5.93%11.49%2.38%

OmniAb Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OABI
OmniAb
2.1102 of 5 stars
$3.39
-1.0%
$9.00
+165.9%
-42.1%$478.02M$20.41M-5.467Positive News
RAMP
LiveRamp
4.4701 of 5 stars
$30.87
-1.2%
$39.33
+27.4%
-13.8%$2.03B$728.71M3,086.501,400
APLD
Applied Digital
3.8533 of 5 stars
$9.02
-15.3%
$12.11
+34.3%
+63.4%$2.01B$165.57M-5.21121
ASTH
Astrana Health
3.8841 of 5 stars
$34.59
-3.1%
$63.00
+82.1%
-39.2%$1.95B$1.72B26.611,800Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
GDRX
GoodRx
3.3792 of 5 stars
$4.84
+0.6%
$8.38
+73.0%
-41.9%$1.84B$750.27M-161.33950Gap Down
High Trading Volume
STGW
Stagwell
2.3685 of 5 stars
$6.66
+5.7%
$8.58
+28.9%
+13.6%$1.75B$2.53B20.5013,000
QBTS
D-Wave Quantum
2.4176 of 5 stars
$6.41
-11.6%
$6.71
+4.7%
+184.9%$1.73B$8.76M-15.263Gap Down
PINC
Premier
3.098 of 5 stars
$18.51
-0.5%
$20.50
+10.8%
-14.0%$1.69B$1.29B-185.082,900Positive News
SEZL
Sezzle
4.1921 of 5 stars
$284.22
-0.8%
$366.00
+28.8%
+503.9%$1.59B$221.81M30.24540Earnings Report
Gap Down
PHR
Phreesia
3.1116 of 5 stars
$27.15
-3.8%
$31.15
+14.8%
+3.3%$1.58B$405.14M-18.471,438Gap Down
DGNX
Diginex
N/A$69.34
+38.7%
N/AN/A$1.57BN/A0.0021Quiet Period Expiration
Gap Down

Related Companies and Tools


This page (NASDAQ:OABI) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners